Investigation Report on China’s Finasteride Market, 2019-2023

Publisher Name :
Date: 04-Sep-2019
No. of pages: 30

The prostate is a male-specific gonadal organ. Benign prostatic hyperplasia (BPH) is the most common benign disease among the causes of urination disorder in middle-aged and elderly men. Epidemiologically, the incidence of BPH increases with age. BPH usually occurs after the age of 40. The incidence in men aged above 60 is higher than 50% and the incidence in men aged above 80 is 83%. Like histologic appearance, symptoms such as dysuria also increase with age. Patients with BPH account for 8% to 11% of urological inpatients, with incidence second only to that of lithangiuria. As the Chinese population ages, BPH will affect the health of more elderly people.

Finasteride is a 4-nitrosteroid hormone compound, a specific type II 5α-reductase inhibitor developed by U.S. company MSD. Since Jun. 1992 when it was approved by the FDA to be sold under trade name Proscar, it has been registered and launched in over 100 countries and regions around the world. After MSD launched Finasteride in China, many Chinese pharmaceutical companies began to develop generic Finasteride. In China, Finasteride is used to treat and control BPH and prevent urinary system events, reduce the risk of acute urinary retention and reduce the risks of transurethral resection of the prostate (TURP) and prostatectomy.

Market survey, in 2003, Zhejiang Xianju Pharmaceutical Co., Ltd. became the first company that was approved by the CFDA to launch generic Finasteride in China. Later, other companies launched their generic Finasteride products in succession. At the end of 2018, about 20 companies were selling Finasteride in China. The brand-name Finasteride by MSD still took up a market share of more than 90%. The sales value of Finasteride kept rising after the drug was launched in China. In 2017, it reached CNY 248 million, representing a CAGR of about 2.00% from 2013 to 2017.

CRI expects that as the Chinese population ages, the incidence of BPH and the number of patients with BPH increase in China and the indications for Finasteride expand, China’s Finasteride market will continue to grow.

Topics Covered:


  • Incidence of benign prostatic hyperplasia in China

  • Status of China’s Finasteride market

  • Competition on China’s Finasteride market

  • Major Finasteride manufacturers in China

  • Prices of Finasteride in China

  • Major factors influencing the development of China’s Finasteride market

  • Prospect of China’s Finasteride market from 2019 to 2023

Investigation Report on China’s Finasteride Market, 2019-2023

Table of Contents

1 Relevant Concepts of Finasteride
1.1 Indications for Finasteride
1.2 Development of Finasteride in China
1.3 Patents and Government Approval on Finasteride in China

2 Sales of Finasteride in China, 2013-2017
2.1 Sales Value of Finasteride
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Finasteride
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Finasteride by Dosage Form in China, 2013-2017
2.3.1 Sales of Finasteride Tablets
2.3.2 Sales of Finasteride Capsules

3 Analysis on Major Finasteride Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Finasteride Manufacturers in China
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 MSD
3.2.1 Enterprise Profile
3.3.2 Sales of Finasteride by MSD in China
3.3 Guangdong Rongtai Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Finasteride by Guangdong Rongtai Pharmaceutical Co., Ltd. in China
3.4 China Meheco Topfond Pharma Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Finasteride in by China Meheco Topfond Pharma Co., Ltd. in China
3.5 China Resources Saike Pharmaceutical Co., Ltd.
3.5.1 Enterprise Profile
3.5.2 Sales of Finasteride in by China Resources Saike Pharmaceutical Co., Ltd. in China
3.6 Zhejiang Xianju Pharmaceutical Co., Ltd.
3.6.1 Enterprise Profile
3.6.2 Sales of Finasteride by Zhejiang Xianju Pharmaceutical Co., Ltd. in China

4 Prices of Finasteride in China, 2017-2018
4.1 MSD (Propecia)
4.2 Guangdong Rongtai Pharmaceutical Co., Ltd.
4.3 China Meheco Topfond Pharma Co., Ltd. (Qiyue)
4.4 China Resources Saike Pharmaceutical Co., Ltd. (Kabo)
4.5 Zhejiang Xianju Pharmaceutical Co., Ltd.

5 Prospect of China’s Finasteride Market, 2019-2023
5.1 Major Factors Influencing Development of China’s Finasteride Market
5.1.1 Favorable Factors
5.1.2 Unfavorable Factors
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts

Chart Patents on Finasteride in China
Chart Government Approval on Finasteride in China
Chart Sales Value of Finasteride in China, 2013-2017
Chart Sales Value of Finasteride in Parts of China, 2013-2017
Chart Sales Volume of Finasteride in China, 2013-2017
Chart Sales Volume of Finasteride in Parts of China, 2013-2017
Chart Sales Value of Finasteride Tablets in China, 2013-2017
Chart Sales Volume of Finasteride Tablets in China, 2013-2017
Chart Sales Value of Finasteride Capsules in China, 2013-2017
Chart Market Share of Top 5 Finasteride Manufacturers by Sales Value in China, 2013-2017
Chart Market Share of Top 5 Finasteride Manufacturers by Sales Volume in China, 2013-2017
Chart Profile of MSD
Chart Sales Value of Finasteride by MSD in China, 2013-2017
Chart Sales Volume of Finasteride by MSD in China, 2013-2017
Chart Profile of Guangdong Rongtai Pharmaceutical Co., Ltd.
Chart Sales Value of Finasteride by Guangdong Rongtai Pharmaceutical Co., Ltd. in China, 2013-2017
Chart Profile of China Meheco Topfond Pharma Co., Ltd.
Chart Profile of China Resources Saike Pharmaceutical Co., Ltd.
Chart Sales Value of Finasteride by China Resources Saike Pharmaceutical Co., Ltd. in China, 2013-2017
Chart Profile of Zhejiang Xianju Pharmaceutical Co., Ltd.
Chart Prices of Finasteride by MSD in Parts of China, 2017-2018
Chart Prices of Finasteride by Guangdong Rongtai Pharmaceutical Co., Ltd. in Parts of China, 2017-2018
Chart Prices of Finasteride by China Meheco Topfond Pharma Co., Ltd. in Parts of China, 2017-2018
Chart Forecast on Sales Value of Finasteride in China, 2019-2023

  • Global Plasma Therapy Market Growth (Status and Outlook) 2019-2024
    Published: 21-Oct-2019        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Plasma Therapy market will register a 10.4% CAGR in terms of revenue, the global market size will reach US$ 286 million by 2024, from US$ 192.7 million in 2019. In particular, this report presents the global revenue market share of key companies in Plasma Therapy business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Plasma Therapy market by product type, applicat......
  • Global Enoxolone Market Professional Survey Report 2019
    Published: 17-Oct-2019        Price: US 3500 Onwards        Pages: 101
    The global Enoxolone market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Enoxolone volume and value at global level, regional level and company level. From a global perspective, this report represents overall Enoxolone market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Enox......
  • Global Liver Disease Treatment Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 110
    The Liver Disease Treatment market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Liver Disease Treatment industrial chain, this report mainly elaborates the definition, types, applications and major players of Liver Disease Treatment market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise prod......
  • Global Biologic Therapeutic Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 111
    The Biologic Therapeutic market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Biologic Therapeutic industrial chain, this report mainly elaborates the definition, types, applications and major players of Biologic Therapeutic market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, ind......
  • Global Liver Disease Treatment Market Study 2016-2026, by Segment (Anti-Rejection Drugs/Immunosupressants, Chemotherapy Drugs, ) , by Market (Adult, Children) , by Company (Gilead Science, Bayer AG, )
    Published: 17-Oct-2019        Price: US 1800 Onwards        Pages: 50
    Summary The global Liver Disease Treatment market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Anti-Rejection Drugs/Immunosupressants - Chemotherapy Drugs - Targeted therapy - Vaccines - Others Demand Coverage (Market Size & Forecast, Consumer Distribution): - Adult - Children ......
  • Global and China Substance Abuse Treatment Market Research by Company, Type & Application 2013-2025
    Published: 16-Oct-2019        Price: US 2000 Onwards        Pages: 69
    Summary Market Segment as follows: By Type - Alcohol Abuse Treatment - Nicotine Abuse Treatment - Drug Abuse Treatment By Application - Hospitals - Clinics - Others By Company - Alkermes - Allergan - GSK - Pfizer - Accord Healthcare - Amphastar Pharmaceuticals - Apotex - BioCorRx - Cipla - Glenmark The main contents of ......
  • Global and China Virus Like Particles Market Research by Company, Type & Application 2013-2025
    Published: 16-Oct-2019        Price: US 2000 Onwards        Pages: 82
    Summary Market Segment as follows: By Type - Adeno-Associated Virus - HIV - Hepatitis B Virus - Hepatitis C Virus - Others By Application - Vaccines - Mycoviruses - Virus Research - Therapeutic and Imaging Agents - Others By Company - GlaxoSmithKline - Merck - Novavax - Takeda - Medicago - MedImmune - TechnoVax - Agilvax......
  • Global Globoid Cell Leukodystrophy Treatment Market Professional Survey Report 2019
    Published: 16-Oct-2019        Price: US 3500 Onwards        Pages: 101
    The global Globoid Cell Leukodystrophy Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Globoid Cell Leukodystrophy Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Globoid Cell Leukodystrophy Treatment market size by analyzing historical data and future prospect. Regionally, thi......
  • Global Clear-Aligner Treatment Market Growth 2019-2024
    Published: 16-Oct-2019        Price: US 3660 Onwards        Pages: 159
    According to this study, over the next five years the Clear-Aligner Treatment market will register a 26.6% CAGR in terms of revenue, the global market size will reach US$ 4606.5 million by 2024, from US$ 1791.6 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Clear-Aligner Treatment business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Clear-Aligne......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs